Premium
Platelet‐derived growth factor‐D expression mediates the effect of differentiated degree on prognosis in epithelial ovarian cancer
Author(s) -
Yang Chunyan,
Zhang Mengjun,
Cai Yuqing,
Rong Zhiwei,
Wang Ce,
Xu Zhenyi,
Xu Huan,
Song Wei,
Hou Yan,
Lou Ge
Publication year - 2019
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.27432
Subject(s) - platelet derived growth factor receptor , ovarian cancer , medicine , epithelial ovarian cancer , oncology , growth factor , metastasis , cancer research , cancer , receptor
Platelet‐derived growth factor‐D (PDGF‐D) can enhance invasion and metastasis in several human malignancies. Although several studies have been performed to investigate the association between clinicopathological characteristics and prognosis in epithelial ovarian cancer (EOC), the mediation effect of PDGF‐D on above‐mentioned association have been seldom assessed. In this study, we detected the PDGF‐D expression from the tissues of patients with EOC and further collected clinicopathological characteristics and prognostic information to identify whether PDGF‐D mediated the effect of differentiated degree on prognosis in patients with EOC. A total of 190 paraffin‐embedded tissue samples from patients with EOC between July 2005 and December 2010 were collected. We performed a Kaplan‐Meier analysis for the association between differentiated degree and prognosis followed by a causal mediation analysis. The analysis results indicated that differentiated degree was associated with prognosis and PDGF‐D mediated the effect of differentiated degree on prognosis in patients with EOC, which might be a potential target for ovarian cancer treatment.